Collaborations & Alliances
Related Searches:
Filter by:
481 - 495 of 1095 results
February 25, 2011
Ipsen and bioMérieux have entered into a global collaboration around theranostics (personalized diagnostic medicine), with a focus on hormone-dependent cancers.
Read More »
February 24, 2011
Prasco Laboratories has signed a distribution and supply agreement with Shire US Manufacturing, Inc. for mesalamine controlled-release capsules.
Read More »
February 23, 2011
Elan and PPD, Inc. have formed a global business collaboration focused on advancing the development of Elan’s portfolio.
Read More »
February 23, 2011
Ingenuity Systems has entered a research collaboration with Covance Genomics Laboratory for next-generation sequencing (NGS) data analysis.
Read More »
February 22, 2011
MorphoSys AG has received a milestone payment from Novartis for the installation of its HuCAL antibody platform at Novartis Institutes for BioMedical Research in Basel, Switzerland.
Read More »
February 16, 2011
BioConvergence and Creapharm have partnered in an effort to provide customers with lower costs, reduced risks, and increased control of projects.
Read More »
February 15, 2011
Takeda’s Pharmaceutical Development Division has entered into strategic partnerships with Covance and Quintiles to plan and execute global development programs to support new compounds in all therapeutic areas, except oncology.
Read More »
February 7, 2011
Pact covers characterization tools, services
Read More »
February 4, 2011
Merck and Galapagos NV have agreed to end their development alliances, and Galapagos has regained worldwide rights for all assets in the programs.
Read More »
January 28, 2011
PharmaNet Development Group, Inc. and Anapharm Europe, S.L., have ended their bioanalytical services joint venture as of December 22, 2010.
Read More »
January 26, 2011
Compound Focus unit to handle liquid chem library collection
Read More »
January 20, 2011
Evotec AG has entered into a collaboration with Takeda Cambridge Ltd., to identify small molecule modulators against GPCR and Protease targets to treat various CNS and Metabolic diseases.
Read More »
January 20, 2011
BioClinica, Inc. has established a strategic partnership with Symbiance Inc., a specialty CRO based in Princeton, NJ.
Read More »
January 13, 2011
Evotec AG has reached a milestone triggering a $2.6 million payment in its research alliance with Boehringer Ingelheim.
Read More »
481 - 495 of 1095 results
